1.A case-control study of the association between anti-Müllerian hormone and ischemic stroke
Xinyu CHEN ; Zhengyuan ZHOU ; Shujun GU ; Chengcheng DUAN ; Qiyu QIAN ; Ru LI ; Huan ZHANG
Chinese Journal of Geriatrics 2024;43(2):175-179
Objective:To investigate the association between plasma anti-Müllerian hormone(AMH) levels and ischemic stroke.Methods:In this case-control study, 93 ischemic stroke patients were randomly selected as the case group from a study on the prevention and treatment of metabolic syndrome, which was conducted in 2018-2019 in Changshu, Jiangsu Province, while 372 nonischemic stroke patients were selected as the control group according to the principle of 1∶4 matching.An enzyme-linked immunosorbent assay was used to measure plasma AMH levels.The conditional logistic regression model and restricted cubic spline were used to analyze the relationship between AMH levels and ischemic stroke.Results:A total of 465 subjects with an average age of (68.7±7.4)years were included in this study, of whom 215(46.2%)were men and 250(53.8%)were women.According to our conditional Logistic regression analysis, the risk of ischemic stroke was reduced by 44% for every unit increase in the log-AMH level( OR=0.56, 95% CI: 0.37-0.85)in the overall population after multivariate adjustment.Compared with the tertile with the lowest AMH level, the risk of ischemic stroke in the tertile with the highest AMH level decreased significantly( OR=0.37, 95% CI: 0.19-0.69). When subgrouped by sex, the tertiles with the highest AMH levels were associated with a 66% lower risk of ischemic stroke in men( OR=0.34, 95% CI: 0.13-0.88)and a 64% lower risk of ischemic stroke in women( OR=0.36, 95% CI: 0.15-0.87), compared with the tertiles with the lowest AMH levels.The results of restricted cubic spline analysis showed that there was a linear dose-response relationship between plasma AMH levels and ischemic stroke both in the general population and in male or female population( Pvalues for linear trends were 0.0002, 0.008 and 0.007, respectively). Conclusions:Higher plasma AMH levels decrease the risk of ischemic stroke with a dose-response pattern.
2.Clustering analysis of risk factors in high-incidence areas of esophageal cancer in Yanting county
Ruiwu LUO ; Heng HUANG ; Hao CHENG ; Siyu NI ; Siyi FU ; Qinchun QIAN ; Junjie YANG ; Xinlong CHEN ; Hanyu HUANG ; Zhengdong ZONG ; Yujuan ZHAO ; Yuhe QIN ; Chengcheng HE ; Ye WU ; Hongying WEN ; Dong TIAN
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery 2024;31(03):385-391
Objective To investigate the dietary patterns of rural residents in the high-incidence areas of esophageal cancer (EC), and to explore the clustering and influencing factors of risk factors associated with high-incidence characteristics. Methods A special structured questionnaire was applied to conduct a face-to-face survey on the dietary patterns of rural residents in Yanting county of Sichuan Province from July to August 2021. Univariate and multivariate logistic regression models were used to analyze the influencing factors of risk factor clustering for EC. Results There were 838 valid questionnaires in this study. A total of 90.8% of rural residents used clean water such as tap water. In the past one year, the people who ate fruits and vegetables, soybean products, onions and garlic in high frequency accounted for 69.5%, 32.8% and 74.5%, respectively; the people who ate kimchi, pickled vegetables, sauerkraut, barbecue, hot food and mildew food in low frequency accounted for 59.2%, 79.6%, 68.2%, 90.3%, 80.9% and 90.3%, respectively. The clustering of risk factors for EC was found in 73.3% of residents, and the aggregation of two risk factors was the most common mode (28.2%), among which tumor history and preserved food was the main clustering pattern (4.6%). The logistic regression model revealed that the gender, age, marital status and occupation were independent influencing factors for the risk factors clustering of EC (P<0.05). Conclusion A majority of rural residents in high-incidence areas of EC in Yanting county have good eating habits, but the clustering of some risk factors is still at a high level. Gender, age, marital status, and occupation are influencing factors of the risk factors clustering of EC.
3.Innovation of Methods for Efficacy Evaluation of Traditional Chinese Medicine Compound Prescriptions: Establishment of Characterization System for Simultaneous Treatment/Regulation Based on Correlation Patterns of Five Zang-organs
Yujie LI ; Tuo LIU ; Luqi WANG ; Lina CHEN ; Yan LIANG ; Chengcheng LIU ; Yu LI ; Xiaoxin ZHU
Chinese Journal of Experimental Traditional Medical Formulae 2024;30(23):19-26
The clinical efficacy advantages of traditional Chinese medicine (TCM) compound prescriptions have always been inadequately characterized in experimental research,which has become a bottleneck restricting the development of TCM pharmacology and even the progress of TCM. The concept of simultaneous treatment/regulation,guided by the theory of mutual generation and restriction of five zang-organs,has guiding significance in the clinical practice of TCM throughout history and is still widely used in the current clinical practice. However,this unique and clinically valuable diagnostic and therapeutic medication system based on the syndrome differentiation has been completely ignored in the modern research of TCM pharmacology,which might be one of the key factors restricting the pharmacological characterization of the therapeutic advantages of TCM compound prescriptions. On the basis of systematically summarizing the phased progress and achievements of the efficacy evaluation of TCM compound prescriptions,this article explores the path of exploring the pharmacological advantages of TCM compound prescriptions on simultaneous treatment/regulation on the basis of the correlation patterns of five zang-organs,from the theory of Zangxiang,the core concept of five zang-organs,and the TCM disease recognition based on the theory of mutual generation and restriction of five zang-organs. With the heart-lung correlation as a breakthrough point,this study explored a new characterization method for the pharmacological advantages of TCM,aiming to provide new ideas for evaluating the efficacy of TCM compound prescriptions.
4.Effect of Artemisinin and Its Derivatives in Treatment of Nervous System Diseases: A Review
Yan LIANG ; Shuiqing QU ; Yu LI ; Yue DAI ; Chengcheng LIU ; Luqi WANG ; Lina CHEN ; Tuo LIU ; Yujie LI
Chinese Journal of Experimental Traditional Medical Formulae 2024;30(23):292-299
With the rapid development of social economy, the number of patients with nervous system diseases has increased, and the incidence of the population has a trend of younger, which has a serious impact on life health and social economy. Artemisinin is an active antimalarial component extracted and isolated from Artemisia annua, a Chinese medicinal material. Artemisinin and its derivatives, in addition to the antimalarial effect, also have anti-parasitic, anti-fungal, anti-viral, hypoglycemic, hypolipidemic, anti-tumor, and anti-inflammatory effects, showing a wide range of pharmacological activities. In the past five years, research on the new pharmacological effects of artemisinin and its derivatives has been deepening, and the efficacy of artemisinin and its derivatives in nervous system diseases has attracted much attention, including anti-neuroinflammation, anti-oxidative stress, maintaining the stability of the blood-brain barrier, regulating the release of neurotransmitters, repairing neuronal damage, and promoting neuronal regeneration. These pharmacological effects indicate that artemisinin and its derivatives are potentially capable of neuroprotection. By sorting out literature on the pharmacological activity of artemisinin and its derivatives in nervous system during 2019-2024, this paper systematically summarized the protective effects of artemisinin and its derivatives against nervous system diseases such as stroke, neurodegenerative diseases, neuroimmunological diseases, neuralgia, and nervous system tumors. This review is expected to provide clues and evidence for new indication expansion of artemisinin drugs, innovative drug development, and clinical treatment of nervous system diseases.
5.Mechanisms of Outdoor Air Pollution Affecting Cardiovascular Diseases: A Review
Chengcheng LIU ; Yu LI ; Yan LIANG ; Shuiqing QU ; Yue DAI ; Tuo LIU ; Lina CHEN ; Luqi WANG ; Yujie LI
Chinese Journal of Experimental Traditional Medical Formulae 2024;30(23):318-326
The impact of air pollution on human health has always been a research hotspot in the global health field. Outdoor air pollutants composed of multiple components can enter the human body through various pathways. Cardiovascular diseases are a group of diseases caused by outdoor air pollutants. Studies have shown that the incidence of cardiovascular diseases, including hypertension, arrhythmia, and heart failure, is significantly increased among people exposed to air pollution environments. Air pollutants such as fine particulate matter, nitrogen dioxide, ozone, carbon monoxide, and sulfur dioxide are closely related to the occurrence of cardiovascular diseases, and short-term and long-term exposure causes different cardiovascular risks. By reviewing the relevant research reports from 2019 to 2024, this article summarizes the epidemiological evidence of cardiovascular diseases caused by different air pollutants. It generalizes the pathways through which air pollutants accelerate the progression of cardiovascular diseases. These pathways include oxidative stress, inflammatory response, thrombosis, extracellular vesicle release, endoplasmic reticulum stress, apoptosis, endothelial dysfunction, autonomic nervous system imbalance, and their interactions. Based on the different mechanisms of air pollution on cardiovascular diseases, the article analyzes the main progress in drug intervention and summarizes the roles of various active ingredients and compound prescriptions of traditional Chinese medicine in treating air pollution-related cardiovascular diseases, providing reference for the research on the mechanisms and drug interventions of air pollution-related cardiovascular diseases.
6.Treatment of Cardiovascular Diseases in Diabetes Mellitus with Traditional Chinese Medicine: A Review
Yu ZHANG ; Yu LI ; Zhongyuan ZHENG ; Yan LIANG ; Chengcheng LIU ; Yue DAI ; Luqi WANG ; Tuo LIU ; Lina CHEN ; Yujie LI
Chinese Journal of Experimental Traditional Medical Formulae 2024;30(23):327-337
The complex pathophysiological mechanisms between diabetes mellitus and cardiovascular diseases have not yet been fully elucidated, becoming one of the challenges in clinical care. Glucagon-like peptide-1 receptor agonist (GLP1-RA) and sodium glucose cotransporter-2 inhibitors (SGLT2) are clinically used to reduce the cardiovascular risk of patients with diabetes mellitus. Traditional Chinese medicine has diverse biological activities and unique advantages in the treatment of chronic complex diseases due to its multi-component and multi-target effects. Based on recent reports, this paper reviewed the common risk factors of diabetes mellitus and cardiovascular diseases (e.g., hyperglycemia, insulin resistance, and inflammation), related targets such as apolipoprotein C-Ⅲ (APOC3), S100 calcium-binding protein A8/A9 (S100A8/A9), growth/differentiation factor-15 (GDF-15), and NACHT, LRR, and PYD domains-containing protein 3 (NLRP3), advanced glycation end products, insulin resistance, endothelial dysfunction, endoplasmic reticulum stress, mitochondrial dysfunction, and intestinal flora disorder. In addition, this paper summarized the research progress in the treatment of cardiovascular diseases in diabetes mellitus with the active ingredients (e.g., baicalein, puerarin, curcumin, notoginsenoside, and tanshinone ⅡA), single herbal medicines (e.g., Astragali Radix, Ginseng Radix et Rhizoma, Sophorae Flavescentis Radix, Cinnamomi Cortex, and Corni Fructus), and compound formulas (e.g., Buzang Tongluo Fang, Yiqi Yangyin Huoxue Fang, Shenqi Fang, Huangqisan, Danggui Buxue Tang, and Liuwei Dihuang Wan) of traditional Chinese medicine. Traditional Chinese medicine mainly treats cardiovascular diseases in diabetes mellitus by reducing inflammation and oxidative stress, ameliorating dyslipidemia and insulin resistance, protecting islet β cell function, repairing endothelial damage, inhibiting smooth muscle cell proliferation, foam cell formation, macrophage polarization, and cardiac hypertrophy and fibrosis, and regulating intestinal flora disorder. These processes involve insulin receptor substrate/ phosphatidylinositol 3-kinase/protein kinase B (IRS/PI3K/Akt), peroxisome proliferator-activated receptor α/γ (PPAR α/γ), nuclear factor-kappa B (NF-κB), adenosine 5′-monophosphate (AMP)-activated protein kinase (AMPK), hypoxia-inducible factor-1-BCH domain-containing protein (HIF-1-BNIP), vascular endothelial growth factor/hypoxia-inducible factor-1α (VEGF/HIF-1α) and other signaling pathways. This review is expected to provide a theoretical basis and reference for the treatment of cardiovascular diseases in diabetes mellitus with traditional Chinese medicine.
7.Role of autophagy in orthodontic tooth movement
Tianqi WANG ; Chengcheng LIAO ; Jianguo LIU ; Lulu CHEN ; Piao ZHAO ; Linlin XIAO ; Xiaoyan GUAN
Chinese Journal of Tissue Engineering Research 2024;28(34):5558-5564
BACKGROUND:The application of orthodontic force triggers autophagy in the periodontal tissue via diverse signaling pathways,augmenting or attenuating the activity of relevant cell types such as periodontal ligament cells,osteocytes,osteoclasts,and osteoblasts,thus facilitating the process of periodontal remodeling. OBJECTIVE:To review the research progress in orthodontic force mediated autophagy in periodontal tissue and its impact on orthodontic tooth movement. METHODS:The PubMed,Web of Science,China Biology Medicine disc and CNKI were searched for literature published from 2010 to 2023 to summarize the progress in orthodontics-related autophagy.And 76 papers were finally included in the analysis and discussion. RESULTS AND CONCLUSION:Orthodontic force can trigger a series of biochemical signal changes through periodontal mechanical receptors and aseptic inflammation they cause,leading to autophagy in periodontal tissue.Subsequently,autophagy generates corresponding feedback through cascaded amplified signaling pathways such as Phosphoinositide 3-kinase/protein kinase B,Hippo,and mitogen-activated protein kinase pathways,promoting periodontal tissue remodeling and ultimately achieving tooth movement and stability.Orthodontic force-induced autophagy can differentially regulate bone resorption on the tooth pressure side and bone formation on the tension side.Related targets have good prospects in the clinical application of orthodontic treatment.Orthodontics and autophagy have complex mechanisms.However,existing research has only focused on exploring the role of autophagy in orthodontic tooth movement.Further exploration is needed to investigate the mutual regulatory effects between autophagy and orthodontic tooth movement,as well as the interactions between upstream mechanical receptors and signaling pathways involved in related pathways.
8.Rho kinase inhibitor Y27632 promotes survival of human induced pluripotent stem cells during differentiation into functional midbrain dopaminergic progenitor cells in vitro
Yangyang LI ; Jiajia XU ; Chengcheng JIANG ; Zilong CHEN ; Ying CHEN ; Mengjiao YING ; Ao WANG ; Caiyun MA ; Chunjing WANG ; Yu GUO ; Changqing LIU
Journal of Southern Medical University 2024;44(2):236-243
Objective To improve the efficiency of induced differentiation of primitive neural epithelial cells derived from human induced pluripotent stem cells(hiPSCs-NECs)into functional midbrain dopaminergic progenitor cells(DAPs).Methods HiPSCs were cultured in mTeSRTM medium containing DMH1(10 μmol/L),SB431542(10 μmol/L),SHH(200 ng/mL),FGF8(100 ng/mL),purmorphamine(2 μmol/L),CHIR99021(3 μmol/L),and N2(1%)for 12 days to induce their differentiation into primitive neuroepithelial cells(NECs).The hiPSCs-NECs were digested with collagenase IV and then cultured in neurobasal medium supplemented with 1%N2,2%B27-A,BDNF(10 ng/mL),GDNF(10 ng/mL),AA,TGF-β,cAMP,and 1%GlutaMax in the presence of different concentrations of Rho kinase inhibitor Y27632,and the culture medium was changed the next day to remove Y27632.Continuous induction was performed until day 28 to obtain DAPs.Results Human iPSCs expressed the pluripotency markers OCT4,SOX2,Nanog,and SSEA1 and were positive for alkaline phosphatase staining.The hiPSCs-NECs were obtained on day 13 in the form of neural rosettes expressing neuroepithelial markers SOX2,nestin,and PAX6.In digested hiPSCs-NECs,the addition of 5 μmol/L Y27632 significantly promoted survival of the adherent cells,increased cell viability and the proportion of S-phase cells(P<0.01),and reduced the rate of apoptotic cells(P<0.05).On day 28 of induction,the obtained cells highly expressed the specific markers of DAPS(TH,FOXA2,NURR1,and Tuj1).Conclusion Treatment with Y27632(5 μmol/L)for 24 h significantly promotes the survival of human iPSCs-NECs during their differentiation into DPAs without affecting the cell differentiation,which indirectly enhances the efficiency of cell differentiation.
9.Prediction of benign and malignant amorphous calcifications in the breast based on clinical and mammographic features
Xinxin LI ; Huiyu DUAN ; Xiaomin TANG ; Dawei ZHOU ; Xiuting CHEN ; Chengcheng MA ; Jing YAN ; Zhizhen GAO
Journal of Practical Radiology 2024;40(8):1276-1280
Objective To investigate the risk factors affecting the malignancy of amorphous calcifications in the breast and to establish a predictive nomogram.Methods Patients with amorphous calcifications detected by mammography were retrospectively collected,clinical data were obtained from electronic medical record(EMR),and the mammographic features of the patients were assessed by diagnostic physicians.The risk factors affecting the malignancy of amorphous calcifications were analyzed to develop a predictive model and to assess the performance of the model.Results A total of 153 amorphous calcifications in 144 patients were included in the study,and the overall malignancy rate of calcifications was 20.92%.Patient's age ≥45 years,linear distribution of calcifications,unilateral single or unilateral multiple calcifications,and a larger maximum ratio of calcification extent all predicted a higher probability of malignancy,establishing a nomogram based on these 4 risk factors,with a 3.65%predicted probability of malig-nancy as the cut-off,33.99%(52/153)of patients were allowed to be spared biopsy.Conclusion Patient's age and the distribution,number,and maximum ratio of calcifications may be the risk predictors of malignancy for amorphous calcifications,with nomogram con-struction for distinguishing benignity from malignancy of amorphous calcifications via combining with mammographic features and clinical data.
10.Effect of calaglitzin combined with Degu insulin liraglutide and pioglitazone metformin in the treatment of obese type 2 diabetes mellitus and its effect on insulin sensitivity
Xiaoyi WANG ; Zhen ZHANG ; Jie HAN ; Hui LIU ; Chengcheng YANG ; Huihui CHEN
Chinese Journal of Endocrine Surgery 2024;18(5):728-732
Objective:To evaluate the efficacy of calaglitzin combined with Degu insulin Liraglutide and pioglitazone metformin in the treatment of obese type 2 diabetes mellitus (T2DM) .Methods:Ninety-nine obese T2DM patients admitted to our hospital from Apr. 2021 to Jun. 2023 were divided into 2 groups according to different treatment methods. The control group ( n=52) were treated with Delgu insulin liraglutide and pioglitazone metformin; the observation group ( n=47) were treated with cagaglizin on the basis of the control group, and both groups were treated for 8 weeks. The therapeutic effect of the two groups was compared. Results:The effective rate of observation group was 95.74% (45/47), higher than that of control group 82.69% (43/52) ( P<0.05). After eight weeks of treatment, the levels of FPG (7.96±0.74) mmol/L, 2hPBG (8.36±1.02) mmol/L and BMI (24.63±1.51) kg/m 2 in the observation group were higher than those in the control group ( P<0.05). After 8 weeks of treatment, HOMA-IR (2.41±0.56) of observation group was lower than that of control group (2.84±0.61), GIR (5.63±0.97) mg·kg -1·min -1 was higher than that of the control group (5.17±0.95) mg·kg -1·min -1 ( P<0.05). After eight weeks of treatment, the levels of TG (4.22±0.43) mmol/L, TC (2.15±0.21) mmol/L and ApoB (1.18±0.14) mmol/L in the observation group were higher than those in the control group (2.49±0.26) mmol/L, (4.69±0.47) mmol/L and (1.45±0.19) mmo l/L ( P<0.05). The incidence of adverse reactions in the observation group was 8.51% (4/47), lower than that in the control group (5.77% (3/52) ( P>0.05) . Conclusion:Taking calaglitzin in combination with Delgu insulin liraglutide and pioglitazone metformin can significantly reduce insulin resistance, increase the sensitivity of peripheral tissues to insulin, reduce blood glucose level and BMI level, and the drug safety is reasonable.

Result Analysis
Print
Save
E-mail